Warner Bros. and DC Studios’ “Clayface” took in $3.5 million from Thursday previews, a modest start for a film that DC is treating as a test of whether its universe can stretch beyond conventional superhero fare. Projections for the weekend run from $25 million to $35 million, though some rival estimates sit lower at $22 million to $28 million.
The budget cushion
The R-rated film cost only $44 million to make, far less than “Superman” or “Supergirl,” so profit should come easily. Overseas it is expected to add $20 million to $25 million, for a global opening of $45 million to $55 million. James Watkins directed. The title character is a shape-shifting Batman enemy, here an actor who undergoes a dangerous medical procedure that goes badly wrong.
A documentary in the way
The sharpest competition does not wear a cape. A24’s “You Can See Everything,” from Nathan Fielder and Lance Oppenheim, opened to $15.6 million in 855 theaters, the biggest launch for a nonmusical documentary in 20 years. The directors filmed Theranos founder Elizabeth Holmes before her 11-year prison sentence, and the film has been building Oscar buzz. It now widens to 2,600 theaters and could earn $20 million to $25 million, enough to contest first place.
Other new films are fighting over the leftovers. Black Bear’s comedy “Wicker,” with Olivia Colman and Alexander Skarsgård, made $620,000 in previews and is expected to reach $6 million to $8 million. Laika’s stop-motion “Wildwood” is aiming for the same range. Sony’s “Klara and the Sun,” with Jenna Ortega and directed by Taika Waititi, is tracking at about $2 million. Sacha Baron Cohen’s “Ali G: Who Iz I?” plays in only 125 theaters before heading to Prime Video.
Horror versus the formula
One critic’s review frames what “Clayface” is trying to do. Batman never appears, and plenty of earlier films have tried to build a movie around a villain with no hero in sight, from the Joker and Venom films to Morbius, Kraven the Hunter and Catwoman. R-rated superhero films are not new either. But the critic calls this the first villain-centered, R-rated body-horror movie.
That is the strategic problem. The review’s answer to whether the DC Universe can pivot to the more lucrative horror market is “No. Not yet.” The film has one foot in each genre. Matt Hagen, played by Tom Rhys Harries, is a young movie star left disfigured after a run-in with a mob boss, and he turns to a scientist, played by Naomi Ackie, with an untested nanotechnology procedure. The early body horror, as his features start to slip, works. Then the powers arrive, and in the critic’s words the film trades “the horror of the uncanny valley for the whiz-bang of the comic book splash page.” More bloodthirsty viewers in the theater, the critic noted, grew restless. The film is short and runs on revenge, and the critic thinks it lacks the style of Darkman or Kill Bill. Its Gotham, the review says, is just Liverpool.
An actor turned monster
The character has deeper roots. Created by Bill Finger and Bob Kane, the first Clayface, Basil Karlo, appeared in Detective Comics #40 in June 1940 as a B-list actor. He went mad when he learned a remake of his horror film “Dread Castle” would be shot without him, and began killing in the guise of a villain he once played. Kane said the 1925 Lon Chaney version of Erik in “The Phantom of the Opera” partly inspired him. Matt Hagen came later, in the comics a treasure hunter changed by a pool of radioactive protoplasm.
For DC, the weekend answer is only partial. Previews of $3.5 million set the floor, and the documentary will decide how high the film climbs.
Sources
Photo: Coolcaesar (CC BY 4.0)





